Penumbra (PEN) Research & Development (2014 - 2026)

Penumbra's (PEN) quarterly Research & Development came in at $22.4 million in Q1 2026, up 1.38% year-on-year from $22.1 million in Q1 2025, and up 2.7% on a QoQ basis from $21.8 million in Q4 2025.

Penumbra (PEN) Research & Development (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Research & Development data on file, last reported at $22.4 million in Q1 2026.

  • On a quarterly basis, Research & Development rose 1.38% year-over-year to $22.4 million in Q1 2026; TTM through Mar 2026 was $90.1 million, a 2.35% decrease from a year earlier, with the FY2025 full-year figure at $89.8 million, down 5.29% from the prior year.
  • Research & Development for Q1 2026 stood at $22.4 million, up from $21.8 million in the prior quarter.
  • Over the last five years, Research & Development for PEN reached as high as $25.2 million in Q3 2024 and fell as low as $18.0 million in Q4 2022.
  • Historically, Research & Development has averaged $21.8 million across 5 years, with a median of $21.8 million in 2025.
  • On a YoY basis, Research & Development climbed as much as 27.41% in 2022 and fell as far as 65.46% in 2022.
  • Year by year, Research & Development stood at $18.0 million in 2022, then rose by 22.14% to $21.9 million in 2023, then slipped by 8.81% to $20.0 million in 2024, then advanced by 8.92% to $21.8 million in 2025, then gained by 2.7% to $22.4 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $22.4 million in Q1 2026, $21.8 million in Q4 2025, and $22.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 767.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 413.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 671.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 263.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 145.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -461.27 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 345.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Penumbra 12.48 Bn 11.87 Bn 253.41 Mn 22.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.38 Mn
Dec 31, 2025 21.79 Mn
Sep 30, 2025 22.68 Mn
Jun 30, 2025 23.22 Mn
Mar 31, 2025 22.08 Mn
Dec 31, 2024 20.01 Mn
Sep 30, 2024 25.21 Mn
Jun 30, 2024 24.94 Mn
Mar 31, 2024 24.63 Mn
Dec 31, 2023 21.94 Mn
Sep 30, 2023 20.96 Mn
Jun 30, 2023 21.54 Mn
Mar 31, 2023 19.99 Mn
Dec 31, 2022 17.96 Mn
Sep 30, 2022 21.32 Mn
Jun 30, 2022 19.56 Mn
Mar 31, 2022 20.56 Mn
Dec 31, 2021 52.00 Mn
Sep 30, 2021 16.73 Mn
Jun 30, 2021 17.74 Mn